Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - COMMON STOCK
Common Stock IMVT - Immunovant, Inc.
14 K
LAST VALUE
8.01%
2 YEAR CAGR
117.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR